ES260630A1 - Proceso para la preparaciën de una vacuna - Google Patents
Proceso para la preparaciën de una vacunaInfo
- Publication number
- ES260630A1 ES260630A1 ES0260630A ES260630A ES260630A1 ES 260630 A1 ES260630 A1 ES 260630A1 ES 0260630 A ES0260630 A ES 0260630A ES 260630 A ES260630 A ES 260630A ES 260630 A1 ES260630 A1 ES 260630A1
- Authority
- ES
- Spain
- Prior art keywords
- larv
- exsheathment
- solution
- astertagia
- reserved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000244206 Nematoda Species 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 238000002347 injection Methods 0.000 abstract 2
- 239000007924 injection Substances 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 abstract 2
- 241001147669 Dictyocaulus viviparus Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 229930182555 Penicillin Natural products 0.000 abstract 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract 1
- 239000005708 Sodium hypochlorite Substances 0.000 abstract 1
- 241000731783 Strongyloides papillosus Species 0.000 abstract 1
- 241000122938 Strongylus vulgaris Species 0.000 abstract 1
- 241000122945 Trichostrongylus axei Species 0.000 abstract 1
- 241000243796 Trichostrongylus colubriformis Species 0.000 abstract 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000008135 aqueous vehicle Substances 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 239000003855 balanced salt solution Substances 0.000 abstract 1
- 239000005018 casein Substances 0.000 abstract 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 1
- 235000021240 caseins Nutrition 0.000 abstract 1
- 238000011109 contamination Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 238000004108 freeze drying Methods 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 230000002061 histotrophic effect Effects 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 238000011534 incubation Methods 0.000 abstract 1
- 230000001524 infective effect Effects 0.000 abstract 1
- 229910001410 inorganic ion Inorganic materials 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000002609 medium Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 238000006213 oxygenation reaction Methods 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 229940049954 penicillin Drugs 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 abstract 1
- 229960005322 streptomycin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/10—Protozoa; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB29943/59A GB894603A (en) | 1959-09-02 | 1959-09-02 | Improvements in or relating to vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES260630A1 true ES260630A1 (es) | 1960-11-16 |
Family
ID=10299732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES0260630A Expired ES260630A1 (es) | 1959-09-02 | 1960-08-27 | Proceso para la preparaciën de una vacuna |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3395218A (en, 2012) |
| BE (1) | BE594481A (en, 2012) |
| CH (1) | CH452111A (en, 2012) |
| ES (1) | ES260630A1 (en, 2012) |
| FR (1) | FR633M (en, 2012) |
| GB (1) | GB894603A (en, 2012) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3676547A (en) * | 1970-09-18 | 1972-07-11 | Lilly Co Eli | Ascaris suum vaccine |
| GB2165749A (en) * | 1984-10-18 | 1986-04-23 | Univ Glasgow | Lungworm vaccines |
| US4814170A (en) * | 1986-03-14 | 1989-03-21 | Aphton Corporation | Method for immunization against and treatment of infection by ectoparasites and endoparasites |
| US4891219A (en) * | 1986-03-14 | 1990-01-02 | Aphton Corporation | Method for immunization against and treatment of infection by ectoparasites and endoparasites |
| GB8619293D0 (en) * | 1986-08-07 | 1986-09-17 | Munn E A | Anthelmintic agents |
| US5843710A (en) * | 1987-07-07 | 1998-12-01 | Biotech Australia Pty. Limited And Csiro | Vaccines against animal parasitic nematodes |
| NZ225295A (en) * | 1987-07-07 | 1991-07-26 | Biotech Australia Pty Ltd | Nematode antigen, its production and vaccines containing it |
| US5948644A (en) * | 1988-09-26 | 1999-09-07 | Biotechnology Australia Pty Ltd. | Polynucleotides encoding excretory/secretory proteins of parasitic nematodes, host cells transformed therewith |
| US20040052817A1 (en) * | 2002-09-13 | 2004-03-18 | Peter Geldhof | Ostertagia vaccine |
| US20060024333A1 (en) * | 2004-07-26 | 2006-02-02 | O'connor Daniel J | Use of parasitic biological agents for prevention and control of allergic and other IgE-mediated disorders |
| US20070087020A1 (en) * | 2005-01-27 | 2007-04-19 | O'connor Daniel J | Use of parasitic biological agents for prevention and control of allergic and other IgE-mediated disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE564575A (en, 2012) * | ||||
| US3010875A (en) * | 1958-03-18 | 1961-11-28 | Becton Dickinson Co | Lyophilized syphilis complement fixation antigen and its preparation |
-
1959
- 1959-09-02 GB GB29943/59A patent/GB894603A/en not_active Expired
-
1960
- 1960-08-27 ES ES0260630A patent/ES260630A1/es not_active Expired
- 1960-08-29 BE BE594481A patent/BE594481A/fr unknown
- 1960-09-01 FR FR837532A patent/FR633M/fr not_active Expired
- 1960-09-01 CH CH986360A patent/CH452111A/de unknown
-
1965
- 1965-11-09 US US507035A patent/US3395218A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US3395218A (en) | 1968-07-30 |
| CH452111A (de) | 1968-05-31 |
| GB894603A (en) | 1962-04-26 |
| BE594481A (fr) | 1960-12-16 |
| FR633M (en, 2012) | 1961-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES260630A1 (es) | Proceso para la preparaciën de una vacuna | |
| US3636196A (en) | Ethylethyleneimine as an inactivation agent | |
| GB930451A (en) | Process for propagating rabies virus | |
| Russell et al. | Mumps Viral Cytolysin: I. Action on Human Epithelial Cells in Tissue Culture | |
| GB809822A (en) | Treatment of materials to improve water-repellency | |
| GB1140316A (en) | Influenza virus sub-unit vaccine | |
| GB607004A (en) | Penicillin manufacture | |
| GB978593A (en) | Method for producing l-homoserine by fermentation | |
| GB811411A (en) | Process for the production of a tissue culture fluid containing infectious hepatitisvirus and a killed vaccine therefrom | |
| US3676547A (en) | Ascaris suum vaccine | |
| GB1049434A (en) | Oxytetracycline | |
| GB643268A (en) | Improved process for the preparation of prolonged effect insulin products | |
| GB767414A (en) | Improvements relating to the production of rabis vaccine | |
| GB1001689A (en) | Process for the production of a rabies vaccine | |
| GB698742A (en) | Fire resistant cloth and a method and solution for producing the same | |
| GB904301A (en) | A composite vaccine for the immunization of dogs and foxes against distemper and hepatitis contagiosa canis | |
| GB968980A (en) | Measles virus vaccine | |
| US1457097A (en) | Vaccine and method of preparing same | |
| GB763482A (en) | Improvements in or relating to the manufacture of fumagillin | |
| Meza-Ruiz et al. | First parasitic ecdysis of Haemonchus conforfus in vitro without stimulation by carbon dioxide | |
| GB940260A (en) | Antitrachoma vaccine | |
| GB846755A (en) | Bovine rhinotracheitis vaccine and methods of production | |
| GB919782A (en) | A process for preparing toxoids of bacterial toxins | |
| US2958629A (en) | Preparation of vaccine with brucella killed by patulin compounds | |
| GB638393A (en) | Improvements in and relating to the production of sterols and their addition products from material containing sterols |